Avance Biosciences Revenue and Competitors

Houston, TX USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Avance Biosciences's estimated annual revenue is currently $11.2M per year.(i)
  • Avance Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Avance Biosciences has 72 Employees.(i)
  • Avance Biosciences grew their employee count by -9% last year.

Avance Biosciences's People

NameTitleEmail/Phone
1
VP IT & EngineeringReveal Email/Phone
2
VP, QualityReveal Email/Phone
3
VP-GMP Biologics QC TestingReveal Email/Phone
4
SupervisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is Avance Biosciences?

We're an advanced genomic services company offering assays compliant with FDA and EPA enforced regulations to assist our customers in their regulatory submissions. Combined, our company's founders possess more than a century of experience in the industry. Throw in a team of leading scientists who have designed and executed countless studies satisfying US, European, and Japanese regulatory agencies, and you've got a powerhouse that has already met the needs of over a hundred pharmaceutical and crop science companies around the world. We offer DNA sequencing, quantitative PCR, and other molecular biology and microbiology techniques to support your cGMP/GLP submissions. For academic and industrial researchers, we also provide research-grade services. For detailed information, please visit www.avancebio.com or send us an email at info@avancebio.com.

keywords:N/A

N/A

Total Funding

72

Number of Employees

$11.2M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.4M72-5%N/A
#2
$15.9M72-5%N/A
#3
$17.5M720%N/A
#4
$17.2M7211%N/A
#5
$12.2M72-9%N/A